BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

428 related articles for article (PubMed ID: 22239848)

  • 21. Kidney injury in cirrhosis: pathophysiological and therapeutic aspects of hepatorenal syndromes.
    Møller S; Krag A; Bendtsen F
    Liver Int; 2014 Sep; 34(8):1153-63. PubMed ID: 24673771
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complications of cirrhosis. II. Renal and circulatory dysfunction. Lights and shadows in an important clinical problem.
    Arroyo V; Jiménez W
    J Hepatol; 2000; 32(1 Suppl):157-70. PubMed ID: 10728802
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Terlipressin and albumin vs albumin in patients with cirrhosis and hepatorenal syndrome: a randomized study.
    Martín-Llahí M; Pépin MN; Guevara M; Díaz F; Torre A; Monescillo A; Soriano G; Terra C; Fábrega E; Arroyo V; Rodés J; Ginès P;
    Gastroenterology; 2008 May; 134(5):1352-9. PubMed ID: 18471512
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hyponatremia in cirrhosis.
    Sigal SH
    J Hosp Med; 2012 Apr; 7 Suppl 4():S14-7. PubMed ID: 22489081
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Vasoconstrictors in the treatment of hepatorenal syndrome].
    Ortega R; Calahorra B; Ginès P
    Nefrologia; 2002; 22 Suppl 5():56-61. PubMed ID: 12107919
    [No Abstract]   [Full Text] [Related]  

  • 26.  Hepatorenal syndrome: Current concepts related to diagnosis and management.
    de Mattos ÁZ; de Mattos AA; Méndez-Sánchez N
    Ann Hepatol; 2016; 15(4):474-81. PubMed ID: 27236146
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.
    Arroyo V; Ginès P; Gerbes AL; Dudley FJ; Gentilini P; Laffi G; Reynolds TB; Ring-Larsen H; Schölmerich J
    Hepatology; 1996 Jan; 23(1):164-76. PubMed ID: 8550036
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hepatorenal syndrome in patients with liver cirrhosis].
    Zaza S; Bonny O; Liaudet L
    Nephrol Ther; 2005 Jul; 1(3):174-82. PubMed ID: 16895684
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hepatorenal syndrome in patients with cirrhosis.
    Moreau R
    J Gastroenterol Hepatol; 2002 Jul; 17(7):739-47. PubMed ID: 12121502
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatorenal syndrome.
    Cárdenas A; Uriz J; Ginès P; Arroyo V
    Liver Transpl; 2000 Jul; 6(4 Suppl 1):S63-71. PubMed ID: 10915194
    [No Abstract]   [Full Text] [Related]  

  • 31. Is spontaneous bacterial peritonitis an inducer of vasopressin analogue side-effects? A case report.
    Vaccaro F; Giorgi A; Riggio O; De Santis A; Laviano A; Rossi-Fanelli F
    Dig Liver Dis; 2003 Jul; 35(7):503-6. PubMed ID: 12870738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fluid retention in cirrhosis: pathophysiology and management.
    Kashani A; Landaverde C; Medici V; Rossaro L
    QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hyponatremia in Cirrhosis: An Update.
    Alukal JJ; John S; Thuluvath PJ
    Am J Gastroenterol; 2020 Nov; 115(11):1775-1785. PubMed ID: 33156095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Terlipressin infusion induces ischemia of breast skin in a cirrothic patient with hepatorenal syndrome.
    Di Micoli A; Bracci E; Cappa FM; Casadio R; Zambruni A; Fontana K; Bernardi M; Trevisani F
    Dig Liver Dis; 2008 Apr; 40(4):304-5. PubMed ID: 18160353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Hepatorenal syndrome in decompensated cirrhosis : A special form of acute renal failure].
    Lenz K; Buder R; Lohr G; Piringer P; Voglmayr M
    Med Klin Intensivmed Notfmed; 2016 Jun; 111(5):440-6. PubMed ID: 27241778
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Renal impairment in liver diseases].
    Gerbes AL; Gülberg V
    Praxis (Bern 1994); 2006 Oct; 95(40):1535-8. PubMed ID: 17048410
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The management of hepatorenal syndrome.
    Carl DE; Sanyal A
    Minerva Gastroenterol Dietol; 2009 Jun; 55(2):207-26. PubMed ID: 19305378
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy and safety of terlipressin in cirrhotic patients with variceal bleeding or hepatorenal syndrome.
    Krag A; Borup T; Møller S; Bendtsen F
    Adv Ther; 2008 Nov; 25(11):1105-40. PubMed ID: 19018483
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging hepatic syndromes: pathophysiology, diagnosis and treatment.
    Bertino G; Privitera G; Purrello F; Demma S; Crisafulli E; Spadaro L; Koukias N; Tsochatzis EA
    Intern Emerg Med; 2016 Oct; 11(7):905-16. PubMed ID: 27273018
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Terlipressin in 30 patients with hepatorenal syndrome: results of a retrospective study.
    von Kalckreuth V; Glowa F; Geibler M; Lohse AW; Denzer UW
    Z Gastroenterol; 2009 Jan; 47(1):21-6. PubMed ID: 19156588
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.